While you are correct in the outline of the article what Im trying to say is that the FDA had other agendas and reasons behind many approvals or not. They were not held accountable for their actions.
In relenzas case, because of the inhalation issues and small sample size of initial trail sample this guy blew relenza away. This Biostatistician didnt take into account its true potential as a Prophylaxis, a antivial or a drug that could save millions in a epidemic. He had all the power to say yes or no and because of bad research he stuffed it up back in 1995.
BTA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
